Columbia University bioethicist Maya Sabatello says a Truth and Reconciliation Commission is needed to confront the structural racism in health care (and society) highlighted by the COVID-19 pandemic.
Cancer patients are especially vulnerable to COVID and would benefit from the protection the vaccine offers, says Gary Schwartz, MD, deputy director of the Herbert Irving Comprehensive Cancer Center.
A strategic decision-making and team-building exercise for hospital executives—developed at Columbia University Mailman School of Public Health—now includes a simulated pandemic.
Viral load, the amount of virus detected in a PCR nasal swab, can be used to predict patient outcomes and guide quarantine decisions, Daniel Griffin says.
When the virus arrived in New York City, VP&S clinicians were redeployed to areas in need, researchers pivoted to COVID research, and students graduated early to help “bend the curve.”
A study of more than 1 million patients has found no increased risk of COVID-19 diagnosis, hospitalization, or complications for users of two common anti-hypertensive medications.
Researchers at Columbia, UCLA, and Northeastern have begun helping the FDA in its effort to monitor the safety and effectiveness of vaccines, including COVID-19 vaccines, and other biologic products.
Columbia’s Evelyn Berger-Jenkins, MD, has co-authored new recommendations to help pediatricians address emotional and behavioral health issues in children during the COVID-19 pandemic.
On World AIDS Day, David Ho, MD, received the National Leadership Recognition Award from the National AIDS Memorial and spoke at a virtual event about the impacts of HIV/AIDS and COVID-19.
This year’s Crown Awards video celebrated our front line heroes—physicians, researchers, staff, students, and trainees—who have responded so valiantly to the COVID-19 pandemic.
A new nationwide study of more than 50,000 individuals—coordinated by Columbia researchers—is now underway to determine factors that predict disease severity and long-term health impacts of COVID-19.
A nasal spray created by Columbia researchers prevented transmission of SARS-CoV-2 in ferrets, suggesting the spray could also prevent transmission of the coronavirus in people.
Compared with adults, children produce a very different antibody response after infection with the new coronavirus, SARS-CoV-2, suggesting they clear the virus easily.